pharmaphorum

DECEMBER 23, 2022

Content automation will deliver as AI fails to live up to the hype. Given the demand to deliver a steady stream of content to meet HCPs’ needs, pharma marketers must react, create, edit, and adapt quickly. Dynamic digital content will drive MLR, health authority collaboration.

Patient Care 105

Patient Care 105

Outsourcing Pharma

AUGUST 15, 2022

Signant Health has partnered with the software company o connect its platforms for the management of clinical supply chain inventory, labels, and content.

Labelling 52

Labelling 52

Pharmaceutical Technology

FEBRUARY 23, 2023

To support the mRNA initiatives, RVAC Medicines will continue to partner with GenScript ProBio for the clinical-stage development and commercial stage of its candidates. Editorial content is independently produced and follows the highest standards of journalistic integrity.

Vaccines 115

Vaccines Communication 115

Viseven

MARCH 27, 2023

The company recognized the need for a digital content factory (DCF) to streamline its digital communication. Viseven was the perfect partner to provide the service as we are a pharmaceutical MarTech provider with more than 13 years of experience. Interested in building your own Digital Content Factory? Let us know!

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

AUGUST 1, 2022

GreenLight Biosciences Human Health chief science officer Amin Khan said: “This is a tremendous opportunity for us to partner with a premier vaccine discovery team and use our mRNA platform to accelerate the development of coronavirus vaccines which are more broadly protective and durable than those currently available.”.

Vaccines 98

Vaccines Immunization 98

pharmaphorum

OCTOBER 19, 2022

Due to the combined impact of emerging technologies, changing provider preferences, and an evolving post-pandemic world, pharma must navigate new ways to engage providers with relevant, science-driven, digital content. Navigating this shift means reframing the way pharma teams approach provider-focused content.

Communication 98

Communication 98

Pharmaceutical Technology

MARCH 8, 2023

We are delighted to be partnering with the CAR T pioneers at Penn and believe that combining our expertise in science and technology will help bring the next generation of cell therapies to patients faster.” Editorial content is independently produced and follows the highest standards of journalistic integrity.

Communication 97

Communication FDA 97

Viseven

JUNE 29, 2023

The essence and creation of such a thing as content have undergone many changes. The human perception of content was everchanging, from simple newspaper columns or advertisements through radio and TV to today’s variety of digital communication channels. How exactly Does the Modular Approach Improve Content Measurement?

Communication 52

Communication 52

pharmaphorum

JUNE 3, 2021

Participants: Paul Tunnah – founder, pharmaphorum, chief content officer & UK MD, Healthware Group. BIO-Europe Spring Digital is produced by EBD Group, a partnering firm for the global life science industry. Jukka Corander – head of AI, Nanoform. Nora Khaldi – Founder and CEO, Nuritas.

87

87

Viseven

JULY 20, 2023

This partnership paves the way for gradual digital transformation across many industries, including Retail, Manufacturing, Finance, and, of course, Pharma and Life Sciences, making high-quality digital content creation, management, and distribution a reality for everyone.

Communication 40

Communication 40

pharmaphorum

JUNE 2, 2022

content wastage of up to 30%, costing millions of dollars. In turn, time-poor healthcare professionals require more meaningful and relevant content at the right time, which helps them better partner with the patient to make the right decisions faster. Importantly the content is not channel?specific—it

Communication 52

Communication FDA 52

Pharmaceutical Technology

SEPTEMBER 9, 2022

Initially, the companies partnered to identify new targets for respiratory and cardiovascular diseases using Gatehouse Bio’s artificial intelligence (AI)-powered platform in December 2019. Editorial content is independently produced and follows the highest standards of journalistic integrity.

Compounding 98

Compounding 98

Pharmaceutical Technology

MARCH 20, 2023

Under the deal, Penn Perelman School of Medicine Vaccine Research Roberts Family Professor Drew Weissman and his laboratory will partner with RVAC Medicines for the development and optimisation of mRNA vaccine candidates that can induce immune tolerance in the body. Topic sponsors are not involved in the creation of editorial content.

Vaccines 98

Vaccines Immunization Communication 98

Pharmaceutical Technology

NOVEMBER 16, 2022

“Deep expertise in autologous cellular therapies manufacturing and analytics combined with its scalable platform for suspension-based lentiviral production, make ElevateBio an ideal partner as we progress our oncogenic driver programmes into the clinic and work to deliver transformative therapies to patients and their families.”.

Immunization 98

Immunization 98

Pharmaceutical Technology

MARCH 28, 2023

CRISPR Therapeutics and ViaCyte, which was acquired by Vertex Pharmaceuticals last year, will continue to partner on their existing gene-edited allogeneic stem cell therapies to treat diabetes under the collaboration terms. Editorial content is independently produced and follows the highest standards of journalistic integrity.

Communication 94

Communication 94

Pharmaceutical Technology

FEBRUARY 16, 2023

Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content. The post MD Anderson and Xilis partner to expedite new cancer therapies development appeared first on Pharmaceutical Technology.

Communication 96

Communication 96

Pharmaceutical Technology

OCTOBER 13, 2022

Inceptor Bio has partnered with cell engineering technology company Avectas to improve CAR-T cell therapies’ development and manufacturing to treat solid tumours. Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content.

59

59

Pharmaceutical Technology

OCTOBER 14, 2022

Pharmaceutical companies Xcell Biosciences (Xcellbio) and aCGT Vector have partnered to expedite the development of cell and gene therapies. Xcellbio co-founder and CEO Brian Feth said: “We are pleased to partner with aCGT Vector and to pair their manufacturing expertise with our unique approach to measuring and improving therapeutic potency.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

OCTOBER 19, 2022

Where next for life sciences’ digital innovation’ under the moderation of pharmaphorum’s founder and Healthware Group’s chief content officer and managing director UK Paul Tunnah. Investments and M&A climate and strategies’ will be moderated by digitalhealth.network’s managing partner, Marc Slujis.

105

105

Pharmaceutical Technology

DECEMBER 5, 2022

According to the latest deal, the University of Queensland (UQ) and Griffith University will serve as foundational partners. Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content. Free Whitepaper.

Vaccines 98

Vaccines Communication Immunization 98

pharmaphorum

FEBRUARY 1, 2021

The two partners say they will develop a specific version of the app for people with psoriasis – called Claro – that will use “cognitive behavioural therapy, positive psychology and mindfulness” to improve the wellbeing of psoriasis patients. The post Almirall, Happify partner on digital tool for psoriasis mental health appeared first on.

124

124

pharmaphorum

JANUARY 11, 2022

Chief Content Officer & Managing Director UK. Sr Partner Digital Therapeutics at Healthware Group. Ariel Salmang. Managing Director, Intouch International. Paul Tunnah. Francis Mahmud Namouk. Global Head of Virtual Customer Experiences & Managing Director, SWM. Petteri Kolehmainen. Managing Director Nordics & Baltics.

98

98

pharmaphorum

SEPTEMBER 9, 2022

The partners anticipate that the digital obesity programme will launch later this autumn in Sweden, ahead of a broader rollout in other European markets before the end of the year. The post Novo Nordisk, Kry partner on digital programme for obesity appeared first on.

113

113

Pharmaceutical Technology

MAY 24, 2023

“Forge is committed to supporting this collaboration with the NIH, the FDA and like-minded partners on the BGTC, to provide a critical development platform that will enable the future of AAV therapies for patients.” Editorial content is independently produced and follows the highest standards of journalistic integrity.

FDA 96

FDA 96

Viseven

JUNE 21, 2023

As one of the prominent providers of martech services in the pharmaceutical and life sciences industries, Viseven always tends to know what’s next for content development, omnichannel engagement, and customer experience. Want to become a Viseven partner too? It’s great to be back and feel the atmosphere of this wonderful event.

Communication 52

Communication 52

pharmaphorum

JANUARY 4, 2022

This designation indicates to customers and partners that PRISYM 360 was successfully tested, confirming its performance and functionality with Zebra ZT400, ZT600 and Xi4 series printers. Zebra Technologies is an innovator at the front line of business with solutions and partners that deliver a performance edge. About PRISYM ID.

Labelling 52

Labelling Packaging 52

Pharma Mirror

NOVEMBER 19, 2021

This year’s smart event was a combination of a three-day live exhibition, and a month-long online event featuring both the latest market insights through live and on demand content sessions and of course networking opportunities. Highlighting the industry’s positivity for the return of in-person networking.

52

52

Pharmaceutical Technology

APRIL 27, 2023

Orbital Therapeutics has raised $270m in a Series A round led by ARCH Venture Partners to advance a portfolio of programmable RNA therapeutics. The initial investors were a16z Bio + Health and Newpath Partners. Editorial content is independently produced and follows the highest standards of journalistic integrity.

Vaccines 52

Vaccines 52

Pharmaceutical Technology

AUGUST 4, 2022

Roche and Poseida will also partner in a research programme for creating and developing next-generation features and enhancements for allogeneic CAR-T therapies. Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content.

59

59

Pharmaceutical Technology

DECEMBER 21, 2022

Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Free Whitepaper.

Vaccines 140

Vaccines Communication 140

pharmaphorum

OCTOBER 27, 2022

Such communications are generally considered as communications to the public, unless verification is required to restrict access, and therefore appropriate safeguards should be taken to ensure content is not promotional. Companies can sponsor website content if the role of the company is made clear.

Communication 98

Communication Packaging Documentation Pharmaceutical Companies 98

Pharmaceutical Technology

FEBRUARY 9, 2023

Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content. The post ReviR Therapeutics partners with Asieris to develop new oncology therapies appeared first on Pharmaceutical Technology.

Communication 96

Communication 96

Pharmaceutical Technology

MARCH 1, 2023

Tevard CEO and co-founder Daniel Fischer said: “Given Vertex’s proven track record of developing novel therapies to treat serious disease, we’re thrilled to partner with them on this important effort. “By Editorial content is independently produced and follows the highest standards of journalistic integrity.

Communication 52

Communication 52

Pharmaceutical Technology

MARCH 10, 2023

The representative said NHSBT plans to continue increasing manufacturing capacity in this way and said, “We are actively pursuing collaborations with external partners.” Editorial content is independently produced and follows the highest standards of journalistic integrity.

Communication 105

Communication 105

Pharmaceutical Technology

DECEMBER 23, 2022

Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Free Whitepaper.

Communication 131

Communication 131

Pharmaceutical Technology

APRIL 21, 2023

We are excited to partner with IBM to develop novel AI models to advance mRNA science, prepare ourselves for the era of quantum computing and ready our business for these game-changing technologies. Editorial content is independently produced and follows the highest standards of journalistic integrity.

98

98

pharmaphorum

OCTOBER 15, 2021

Prior to that, Eugene held pharmacy benefit management, consulting and pharmaceutical company leadership roles, with his most recent role being at Bayer where he led a global digital health team investing, partnering and building ventures.

Pharmaceutical Companies 124

Pharmaceutical Companies Pharmaceutical Companies 124